IBD (IBD) Stock Price & Analysis

IBD (IBD) fell 0.13% to USD 23.76 as of June 10, 2026 at 12:15 UTC, according to Nexqual real-time market data.

IBD last closed at USD 23.79; the session ranged USD 23.68–23.88 on volume of 138,969 shares. Market capitalization is —, with a 52-week range of USD 23.51–24.85 (PCX). Source: Nexqual, June 10, 2026 at 12:15 UTC.

Key Statistics (as of June 10, 2026 at 12:15 UTC)

PriceUSD 23.76
Change▼ 0.13% (down)
Previous CloseUSD 23.79
OpenUSD 23.79
Day RangeUSD 23.68 – 23.88
52-Week RangeUSD 23.51 – 24.85
Volume138,969 shares
Market Cap
ExchangePCX

Technical Analysis (IBD)

Nexqual's technical model rates IBD "STRONG SELL" based on 0 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 12:15 UTC.

Overall SignalSTRONG SELL
RSI (14)46.48 (neutral)
vs SMA50Below (USD 23.86)
MACD-0.02 (negative)

Financial Health Score (IBD)

Nexqual rates IBD's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 12:15 UTC.

GrowthMixed — No data
ProfitabilityMixed — No data
Balance SheetMixed — No data
Cash FlowMixed — No data
EfficiencyMixed — No data

Peers & Related Stocks

SymbolNamePriceChange
ISMDInspire Small/Mid Cap ETFUSD 46.93▲ 0.95%
BLESInspire Global Hope ETFUSD 47.56▲ 0.01%
BIBLInspire 100 ETFUSD 54.62▲ 1.2%
WWJDInspire International ETFUSD 38.65▲ 0.97%
RISNInspire Capital Appreciation ETUSD 30.9▲ 0.61%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 12:15 UTC. This page is informational and not investment advice.